Use of α- (8-quinolinyloxy) monosubstituted phthalocyanine zinc for treating psoriasis

摘要

The present invention relates to the use of α- (8-quinolinyloxy) monosubstituted zinc phthalocyanine for treating psoriasis. Adopt photodynamic therapy and apply to each type of psoriasis. The photosensitizer has a laser wavelength of 670 nm used to treat psoriasis, has high photosensitivity, fast photobleaching, requires a short light-reducing time, and is irradiated with ultraviolet rays in photodynamic therapy. Avoided toxic side effects due to use. For the use of α- (8-quinolinyloxy) mono-substituted phthalocyanine zinc to treat psoriasis, the formulations used include solutions, creams, nanomicelles, microparticles and the like. The dosing method may be systemic dosing or local dosing. In cell and animal models, it was verified that psoriasis can be performed by photodynamic therapy, and the ideal effect was obtained.